Past Podcast Episodes

You can't control the weather, but you can learn to dance in the rain. And developing resilience teaches you how to dance in the rain. My guest is Dr. Dawn Ehde, a clinical psychologist and professor of rehabilitation medicine at University of Washington Medicine. Dr. Ehde is an expert in understanding resilience, and she's joining us to explain why having resilience is central to improving the well-being of people affected by MS, and how to go about building your resilience — even in the midst of a global pandemic.

We're also talking about Bafiertam, a lower-cost, FDA-approved bioequivalent to Tecfidera.

We'll share the results of a study of more than 5,000 people who were newly diagnosed with MS — and not prescribed a disease-modifying therapy for two years following their diagnosis. We'll also explain why that's just wrong!

We'll talk to Suzi Claflin, the academic lead for Understanding Multiple Sclerosis, a free comprehensive 6-week online course that's open for registration right now.

And we'll remind you about where you can register for next week's Black MS Experience Summit.

We have a lot to talk about! Are you ready for RealTalk MS??!

We're celebrating 3 amazing years! :22

The joint ACTRIMS-ECTRIMS meeting took place last weekend and that means a bonus episode of RealTalk MS is coming 2:38

Bafiertam is now available in the United States 4:44

Study shows that 2/3 of people newly diagnosed with MS in the U.S. are not prescribed any disease-modifying therapy for 2 years following their diagnosis 5:43

Understanding Multiple Sclerosis, a free online course, is open for registration. My interview with Suzi Claflin 8:44

The Black MS Experience Summit takes place next week 21:51

My Interview with Dr. Dawn Ehde 23:43

Share this episode 40:32

Donate to the National MS Society COVID-19 Response Fund 40:52

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/159

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

Bafiertam

STUDY: Treatment Patterns and Comorbid Burden of Patients Newly Diagnosed with Multiple Sclerosis in the United States

“Understanding Multiple Sclerosis” Online Course Registration

National MS Society Black MS Experience Summit

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 159
Guests: Dr. Dawn Ehde

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, UWMedicine, RealTalkMS

Privacy Policy

Disease-modifying therapies are the cornerstone of any effective MS treatment plan. But with more than 20 approved prescription medications available today, the choices can seem overwhelming.

People living with MS have questions — Do you start out with a safe but less effective medication, or do you hit MS hard with a high-efficacy drug that may carry more risks? When is the right time to consider switching medications, and how do you have that conversation with your neurologist? Do things like other health conditions affect which disease-modifying therapy you're on? And what about aging?

My guest is Dr. Scott Newsome, an Associate Professor of Neurology, and Director of Neurosciences Consultation and Infusion Center at Johns Hopkins Medicine. Dr. Newsome also serves as the Co-Director of the Multiple Sclerosis Experimental Therapeutics Program at Johns Hopkins. And I'm devoting this entire episode of RealTalk MS to taking a deep-dive into disease-modifying therapies with Dr. Newsome.

We'll also share the details about two major events taking place this week — the MSVirtual2020 conference and the Keep Moving Forward benefit celebrating the MS Movement.

We have a lot to talk about! Are you ready for RealTalk MS??!

ECTRIMS + ACTRIMS = MSVirtual2020 :24

Don't miss Keep Moving Forward 1:08

My Interview with Dr. Scott Newsome 1:38

Share this episode 33:06

Leave a rating & review 33:26

Please Support the National MS Society COVID-19 Response Fund 34:45

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: realtalkms.com/158

ADD YOUR VOICE TO THE CONVERSATION

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 158
Hosted By: Jon Strum
Guests: Dr. Scott Newsome

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, Tecfidera, Ocrevus, Kesimpta, Copaxone, Gilenya, RealTalkMS

Privacy Policy

Episode 159: Resilience and MS with Dr. Dawn Ehde

Episode 158: A Deep Dive Into MS Disease-Modifying Therapies with Dr. Scott Newsome